SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-050662
Filing Date
2018-09-12
Accepted
2018-09-12 17:12:16
Documents
2
Period of Report
2018-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2294
2 POA DOCUMENT poa.txt EX-24.3_809251 3691
  Complete submission text file 0001209191-18-050662.txt   7376
Mailing Address 749 N MARY AVE SUNNYVALE CA 94085
Business Address
GRYSKA DAVID W (Reporting) CIK: 0001202335 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36152 | Film No.: 181067373

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)